Spirocyclic NK1 antagonists I:: [4.5] and [5.5]-spiroketals

被引：25
|
作者：
Seward, EM
Carlson, E
Harrison, T
Haworth, KE
Herbert, R
Kelleher, FJ
Kurtz, MM
Moseley, J
Owen, SN
Owens, AP
Sadowski, SJ
Swain, CJ
Williams, BJ
机构：
[1] Merck Sharp & Dohme Res Labs, Dept Med Chem, Ctr Res Neurosci, Harlow, Essex, England
[2] Merck Sharp & Dohme Res Labs, Dept Pharmacol, Ctr Res Neurosci, Harlow, Essex, England
[3] Merck Res Labs, Dept Biochem, Rahway, NJ 07065 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2002年 / 12卷 / 18期
关键词：
D O I：
10.1016/S0960-894X(02)00506-1
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A series of novel spiroketal-based NK1 antagonists is described. The effect of modifications to the spiroether ring and aromatic substituents are discussed, leading to the identification of compounds with high affinity and excellent CNS penetration. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：2515 / 2518
页数：4
相关论文
共 50 条
  • [41] A fluorescence and chiroptical investigation on novel NK1 tachykinin receptor antagonists
    Cavalieri, F
    Venanzi, M
    Sisto, A
    Pispisa, B
    SPECTROSCOPY OF BIOLOGICAL MOLECULES: MODERN TRENDS, 1997, : 477 - 478
  • [42] NK1 receptor antagonists for depression: Why a validated concept was abandoned
    Rupniak, Nadia M. J.
    Kramer, Mark S.
    JOURNAL OF AFFECTIVE DISORDERS, 2017, 223 : 121 - 125
  • [43] Novel lactam NK1 antagonists with anti-emetic activity
    Hollingworth, GJ
    Carlson, EJ
    Castro, JL
    Chicchi, GG
    Clark, N
    Cooper, LC
    Dirat, O
    Di Salvo, J
    Elliott, JM
    Kilburn, R
    Kurtz, MM
    Rycroft, W
    Tattersall, FD
    Tsao, KL
    Swain, CJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (05) : 1197 - 1201
  • [44] Design, Synthesis, and Optimization of Balanced Dual NK1/NK3 Receptor Antagonists
    Hanessian, Stephen
    Jennequin, Thomas
    Boyer, Nicolas
    Babonneau, Vincent
    Soma, Udaykumar
    la Cour, Clotilde Mannoury
    Millan, Mark J.
    De Nanteuil, Guillaume
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (05): : 550 - 555
  • [45] Identification of novel NK1/NK3 dual antagonists for the potential treatment of schizophrenia
    Catalani, Maria Pia
    Alvaro, Giuseppe
    Bernasconi, Giovanni
    Bettini, Ezio
    Bromidge, Steven M.
    Heer, Jag
    Tedesco, Giovanna
    Tommasi, Simona
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (22) : 6899 - 6904
  • [46] Combined NK1 and NK2 receptor antagonists on the bronchoconstrictor response to NKA in dogs
    Chapman, RW
    Schilling, A
    Ng, K
    Nardo, C
    Kreutner, W
    Young, S
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 1999, 12 (04) : 261 - 266
  • [47] L-tryptophan urea amides as NK1/NK2 dual antagonists
    Qi, HB
    Shah, SK
    Cascieri, MA
    Sadowski, SJ
    MaCcoss, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (16) : 2259 - 2262
  • [48] Preparation of oxime dual NK1/NK2 antagonists with reduced NK3 affinity
    Reichard, GA
    Grice, CA
    Shih, NY
    Spitler, J
    Majmundar, S
    Wang, SD
    Paliwal, S
    Anthes, JC
    Piwinski, JJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (17) : 2355 - 2358
  • [49] NK1 antagonist
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1997, 2 (04) : 162 - 162
  • [50] Serine derived NK1 antagonists 1:: The effect of modifications to the serine substituents.
    Elliott, JM
    Cascieri, MA
    Chicchi, G
    Davies, S
    Kelleher, FJ
    Kurtz, M
    Ladduwahetty, T
    Lewis, RT
    MacLeod, AM
    Merchant, KJ
    Sadowski, S
    Stevenson, GI
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (14) : 1845 - 1850
12345